Therefore, it is important to place in perspective a historical timeline of preclinical models used in research and development to study the effects of leptin in obesity and T2DM (Figure 1) [9,10,11,12,13,14,15,16,17,18,19]. This evidence concerns the gene LEP and type 2 diabetes mellitus.